Schonfeld Strategic Advisors LLC Lannett CO Inc Transaction History

Schonfeld Strategic Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$13.3 - $17.45 $1.09 Million - $1.43 Million	-81,827 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$14.7 - $24.95 $1.2 Million - $2.04 Million	81,827 New	81,827 $1.31 Million
Q4 2017 Feb 14, 2018	SELL	$19.9 - $29.25 $392,248 - $576,546	-19,711 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$15.1 - $19.25 $297,636 - $379,436	19,711	19,711 $364,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.